Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER)

Overview of attention for article published in Health and Quality of Life Outcomes, April 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Dimensions has found 13 publications that cite this research output.

Article in Current Bladder Dysfunction Reports (January 2024)

Article in International Journal of Women's Health (May 2023)

Article in Trials (April 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.